首页 > 最新文献

Ophthalmic and Physiological Optics最新文献

英文 中文
Retinal shadows of multisegment lenses in fundus imaging. 眼底成像中多节段晶状体的视网膜阴影。
IF 2.8 3区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-07-01 Epub Date: 2025-05-14 DOI: 10.1111/opo.13524
Arthur Ho, Lisa Feng, Jos J Rozema, David A Atchison

Purpose: To provide a more sophisticated explanation of the optics involved when retinal 'shadows' are seen in scanning laser ophthalmoscopic images during the wear of multisegment and diffusion optic spectacle lenses.

Methods: Images were recorded with a system that uses a scanning broad line fundus imaging principle in participants with undilated pupils wearing a multisegment spectacle lens. The live infra-red preview display of the system was also acquired during image recording. Ray-tracing and image simulations were performed, assuming a Maxwellian illumination system in which a source was refracted first through a lens and then through a model of a multisegment spectacle lens focused onto the pupil of an eye model and hence to the retina. A detector surface was positioned slightly in front of the retina to record the irradiation distribution. The light source was varied from 0.1 μm to 1.8 mm in diameter to investigate the effect of light source size on retinal irradiation distribution.

Results: The retinal shadow pattern was visible on the live infra-red preview display, as reported previously. However, the recorded images of the retina do not exhibit the same shadow pattern. The simulations predict that the circular shadows corresponding to lenslet positions become progressively less discernible with increasing light source size.

Conclusion: An explanation is provided for the shadows on retinal images due to multisegment lenses, which may be observable under certain illumination conditions.

目的:对多段式和扩散式光学镜片佩戴过程中扫描激光检眼镜图像中出现视网膜“阴影”所涉及的光学问题提供更复杂的解释。方法:采用扫描宽线眼底成像原理,对瞳孔未放大的受试者配戴多节段眼镜进行图像记录。在图像记录过程中,还获得了系统的实时红外预览显示。光线追踪和图像模拟进行,假设一个麦克斯韦照明系统中,光源首先通过一个透镜,然后通过一个多段眼镜透镜聚焦到眼睛模型的瞳孔上,从而到达视网膜。检测器表面略位于视网膜前方,记录照射分布。光源直径为0.1 μm ~ 1.8 mm,研究光源尺寸对视网膜辐照分布的影响。结果:在实时红外预览显示器上可见视网膜阴影图案,如前所述。然而,视网膜的记录图像并没有显示出相同的阴影模式。模拟预测,随着光源尺寸的增加,与透镜位置相对应的圆形阴影逐渐变得难以辨认。结论:解释了在一定光照条件下,多节段透镜在视网膜图像上可见的阴影现象。
{"title":"Retinal shadows of multisegment lenses in fundus imaging.","authors":"Arthur Ho, Lisa Feng, Jos J Rozema, David A Atchison","doi":"10.1111/opo.13524","DOIUrl":"10.1111/opo.13524","url":null,"abstract":"<p><strong>Purpose: </strong>To provide a more sophisticated explanation of the optics involved when retinal 'shadows' are seen in scanning laser ophthalmoscopic images during the wear of multisegment and diffusion optic spectacle lenses.</p><p><strong>Methods: </strong>Images were recorded with a system that uses a scanning broad line fundus imaging principle in participants with undilated pupils wearing a multisegment spectacle lens. The live infra-red preview display of the system was also acquired during image recording. Ray-tracing and image simulations were performed, assuming a Maxwellian illumination system in which a source was refracted first through a lens and then through a model of a multisegment spectacle lens focused onto the pupil of an eye model and hence to the retina. A detector surface was positioned slightly in front of the retina to record the irradiation distribution. The light source was varied from 0.1 μm to 1.8 mm in diameter to investigate the effect of light source size on retinal irradiation distribution.</p><p><strong>Results: </strong>The retinal shadow pattern was visible on the live infra-red preview display, as reported previously. However, the recorded images of the retina do not exhibit the same shadow pattern. The simulations predict that the circular shadows corresponding to lenslet positions become progressively less discernible with increasing light source size.</p><p><strong>Conclusion: </strong>An explanation is provided for the shadows on retinal images due to multisegment lenses, which may be observable under certain illumination conditions.</p>","PeriodicalId":19522,"journal":{"name":"Ophthalmic and Physiological Optics","volume":" ","pages":"1098-1103"},"PeriodicalIF":2.8,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12153018/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144037392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Subjective refraction and prescribing styles used by UK optometrists. 英国验光师使用的主观屈光和处方风格。
IF 2.8 3区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-07-01 Epub Date: 2025-04-03 DOI: 10.1111/opo.13495
Jeremy Beesley, Christopher J Davey, David B Elliott

Purpose: To investigate the methods of subjective refraction and prescribing used by UK optometrists in routine eye examinations.

Methods: Following a pilot study of 12 observed refractions conducted by nine optometrists, a questionnaire consisting of simple questions regarding methods used together with conditional response clinical vignettes was constructed. Paper copies were distributed to UK optometrists attending continuing professional development (CPD) courses, in addition to an online version.

Results: Two hundred and four completed questionnaires were gathered from respondents with a mean experience of 16 years (SD, 12 years). Poor technique was defined as likely to contribute to or cause a recheck according to a previous study. Poor techniques seen included visual acuity (VA) not being measured to a full threshold level by 93% of respondents, 37% (55/149) prescribing a small oblique cylinder to an asymptomatic patient and 39% (71/183) making just one subjective change to the axis of a -1.00 D cylinder from their starting prescription before prescribing that axis change to a mildly symptomatic patient. The risk of over-plusing was identified, with 28% (N = 46) of respondents happy to prescribe a full objective +0.50 DS change to a patient with no distance-related symptoms. Symptoms, prescription change and VAs are often not reconciled, with 43% (82/189) of respondents reporting being happy to prescribe a full subjective change of -2.00 DS together with -0.75 DC for a 72-year-old patient for a relatively small VA improvement of 6/15 to 6/7.5.

Conclusions: Poor subjective refraction and prescribing techniques were identified; limited measurement of VA to full threshold, risk of over-plusing/under-minusing, limited cylinder power and axis techniques and symptoms often not reconciling with changes in prescription and improvements in VA were observed. The objective prescription, particularly as determined by autorefractors, holds an exaggerated influence over some optometrists. These are elements of everyday optometry, yet require greater emphasis in CPD.

目的:调查英国验光师在常规眼科检查中使用的主观屈光和处方方法:在对九名验光师进行的 12 次观察屈光试验研究之后,编制了一份调查问卷,其中包括有关所用方法的简单问题以及条件反应临床案例。除了在线版本外,还向参加继续职业发展(CPD)课程的英国验光师发放了纸质问卷:从平均从业年限为 16 年(SD,12 年)的受访者中收集到了 24 份填写完整的问卷。根据之前的一项研究,不良技术被定义为可能导致或引起复查的技术。不良技术包括:93%的受访者未将视力(VA)测量到完整的阈值水平;37%(55/149)的受访者为无症状的患者开具了小斜度镜;39%(71/183)的受访者在为症状轻微的患者开具改变轴位的处方前,仅主观改变了-1.00 D度数镜筒的轴位。28%(N=46)的受访者乐于为没有距离相关症状的患者开具客观+0.50DS的全量改变处方,这表明存在过度用药的风险。症状、度数变化和视力往往无法协调,43%(82/189)的受访者表示乐于为一位 72 岁的患者开具主观变化为-2.00 DS 和-0.75 DC 的处方,而视力改善幅度相对较小,从 6/15 到 6/7.5:发现主观屈光度数和处方技术不佳;测量VA至全阈值有限、过度使用/减少使用的风险、有限的镜筒功率和轴技术以及症状往往与处方的变化和VA的改善不一致。客观度数,尤其是由自动折射仪确定的客观度数,对一些验光师有夸大的影响。这些都是日常验光的要素,但在持续专业发展中需要更加重视。
{"title":"Subjective refraction and prescribing styles used by UK optometrists.","authors":"Jeremy Beesley, Christopher J Davey, David B Elliott","doi":"10.1111/opo.13495","DOIUrl":"10.1111/opo.13495","url":null,"abstract":"<p><strong>Purpose: </strong>To investigate the methods of subjective refraction and prescribing used by UK optometrists in routine eye examinations.</p><p><strong>Methods: </strong>Following a pilot study of 12 observed refractions conducted by nine optometrists, a questionnaire consisting of simple questions regarding methods used together with conditional response clinical vignettes was constructed. Paper copies were distributed to UK optometrists attending continuing professional development (CPD) courses, in addition to an online version.</p><p><strong>Results: </strong>Two hundred and four completed questionnaires were gathered from respondents with a mean experience of 16 years (SD, 12 years). Poor technique was defined as likely to contribute to or cause a recheck according to a previous study. Poor techniques seen included visual acuity (VA) not being measured to a full threshold level by 93% of respondents, 37% (55/149) prescribing a small oblique cylinder to an asymptomatic patient and 39% (71/183) making just one subjective change to the axis of a -1.00 D cylinder from their starting prescription before prescribing that axis change to a mildly symptomatic patient. The risk of over-plusing was identified, with 28% (N = 46) of respondents happy to prescribe a full objective +0.50 DS change to a patient with no distance-related symptoms. Symptoms, prescription change and VAs are often not reconciled, with 43% (82/189) of respondents reporting being happy to prescribe a full subjective change of -2.00 DS together with -0.75 DC for a 72-year-old patient for a relatively small VA improvement of 6/15 to 6/7.5.</p><p><strong>Conclusions: </strong>Poor subjective refraction and prescribing techniques were identified; limited measurement of VA to full threshold, risk of over-plusing/under-minusing, limited cylinder power and axis techniques and symptoms often not reconciling with changes in prescription and improvements in VA were observed. The objective prescription, particularly as determined by autorefractors, holds an exaggerated influence over some optometrists. These are elements of everyday optometry, yet require greater emphasis in CPD.</p>","PeriodicalId":19522,"journal":{"name":"Ophthalmic and Physiological Optics","volume":" ","pages":"1113-1125"},"PeriodicalIF":2.8,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12153031/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143772696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mapping glaucoma higher qualifications within UK optometry. 测绘青光眼在英国验光更高的资格。
IF 2.8 3区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-07-01 Epub Date: 2025-04-07 DOI: 10.1111/opo.13502
Nurfitnat Ellek, Patrick J G Gunn, Michael Bowen, Robert A Harper

Purpose: The chronic capacity crisis in secondary care glaucoma services has resulted in calls to expand contributions by primary care optometrists. This study aims to map the current geographic spread of optometrists with post-graduate higher qualifications in glaucoma and independent prescribing (IP) within the UK, providing insight into the potential for expansion of capacity in glaucoma care.

Methods: Data on glaucoma-related and IP higher qualifications accredited by the College of Optometrists, as of April and August 2024, respectively, were analysed. The geographic distribution was mapped at both regional and local district levels using Quantum Geographic Information System software, geolocation application programming interface (postcodes.io) and programming languages JavaScript and Structured Query Language. Results for 2024 were compared with those previously published to determine change over time.

Results: From 2021 to 2024, the number of optometrists with higher qualifications in glaucoma has increased: Professional Certificate holders rose by 48% to 1986, Higher Certificate holders by 29% to 223, Diploma holders by 49% to 145, those with both Diploma and IP qualifications by 57% to 127 and IP alone holders by 88% to 1952. Regional variations appear to persist.

Conclusion: The number of optometrists holding postgraduate higher qualifications in glaucoma and IP in the UK has increased substantially. These data suggest that primary care optometrists are willing to upskill to gain the necessary glaucoma accreditations required to provide glaucoma care, potentially affording significant primary care capacity expansion to existing glaucoma services.

目的:二级保健青光眼服务的慢性能力危机导致呼吁扩大初级保健验光师的贡献。本研究旨在绘制目前在英国拥有青光眼和独立处方(IP)研究生更高资格的验光师的地理分布,为扩大青光眼护理能力的潜力提供见解。方法:分别分析截至2024年4月和8月由美国验光师学院(College of optometric)认可的青光眼相关资格和IP高等资格的数据。利用量子地理信息系统软件、地理定位应用程序编程接口(postcodes.io)和编程语言JavaScript和结构化查询语言,绘制了区域和地方区级的地理分布图。2024年的结果与之前公布的结果进行了比较,以确定随时间的变化。结果:从2021年到2024年,拥有青光眼更高资格的验光师数量有所增加:专业证书持有者增加48%,达到1986人;高级证书持有者增加29%,达到223人;文凭持有者增加49%,达到145人;文凭和知识产权证书持有者增加57%,达到127人;知识产权证书持有者增加88%,达到1952人。地区差异似乎持续存在。结论:在英国,持有青光眼和IP研究生高等学历的验光师数量大幅增加。这些数据表明,初级保健验光师愿意提高技能,以获得提供青光眼护理所需的必要青光眼认证,这可能为现有青光眼服务提供重大的初级保健能力扩展。
{"title":"Mapping glaucoma higher qualifications within UK optometry.","authors":"Nurfitnat Ellek, Patrick J G Gunn, Michael Bowen, Robert A Harper","doi":"10.1111/opo.13502","DOIUrl":"10.1111/opo.13502","url":null,"abstract":"<p><strong>Purpose: </strong>The chronic capacity crisis in secondary care glaucoma services has resulted in calls to expand contributions by primary care optometrists. This study aims to map the current geographic spread of optometrists with post-graduate higher qualifications in glaucoma and independent prescribing (IP) within the UK, providing insight into the potential for expansion of capacity in glaucoma care.</p><p><strong>Methods: </strong>Data on glaucoma-related and IP higher qualifications accredited by the College of Optometrists, as of April and August 2024, respectively, were analysed. The geographic distribution was mapped at both regional and local district levels using Quantum Geographic Information System software, geolocation application programming interface (postcodes.io) and programming languages JavaScript and Structured Query Language. Results for 2024 were compared with those previously published to determine change over time.</p><p><strong>Results: </strong>From 2021 to 2024, the number of optometrists with higher qualifications in glaucoma has increased: Professional Certificate holders rose by 48% to 1986, Higher Certificate holders by 29% to 223, Diploma holders by 49% to 145, those with both Diploma and IP qualifications by 57% to 127 and IP alone holders by 88% to 1952. Regional variations appear to persist.</p><p><strong>Conclusion: </strong>The number of optometrists holding postgraduate higher qualifications in glaucoma and IP in the UK has increased substantially. These data suggest that primary care optometrists are willing to upskill to gain the necessary glaucoma accreditations required to provide glaucoma care, potentially affording significant primary care capacity expansion to existing glaucoma services.</p>","PeriodicalId":19522,"journal":{"name":"Ophthalmic and Physiological Optics","volume":" ","pages":"1221-1227"},"PeriodicalIF":2.8,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143795911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical evaluation of MyoCare in Europe (CEME) for myopia management: One-year results. 欧洲心肌治疗近视的临床评价:一年的结果。
IF 2.8 3区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-06-01 Epub Date: 2025-04-29 DOI: 10.1111/opo.13517
Cristina Alvarez-Peregrina, Miguel Angel Sanchez-Tena, Cesar Villa-Collar, Clara Martinez-Perez, Beatriz de Corcuera-Terrero, Nicole Liu, Wayne Li, Padmaja Sankaridurg, Arne Ohlendorf

Aims: To evaluate the efficacy of CARE spectacle lenses in slowing myopia progression among European children.

Methods: In a 2-year randomised, parallel-group, double-masked, multicentre clinical trial, 234 European children aged 6-13 years were enrolled. All participants were myopic, with a cycloplegic spherical equivalent refractive error (SE) between -0.75 D and -5.00 D, astigmatism ≤1.50 D, anisometropia ≤1.00 D and myopia progression of at least 0.50 D in the previous year. The treatment group received MyoCare spectacle lenses with cylinder annular refractive elements (CARE), the control group single-vision lenses (SVL). Axial length (AL) and SE were measured at baseline, 6 and 12 months. Wearability questionnaires were administered at 1 week and 3 months. Central and peripheral visual acuity (VA) was recorded at dispensing and after 3 months. Generalised linear models estimated changes in SE and AL, adjusting for lens type, age and baseline measurements.

Results: After 12 months, children wearing CARE lenses showed less myopia progression, with a difference in SE and AL progression (compared to SVL) of -0.21 D (CI: 0.10 to 0.32 D) and 0.14 mm (CI: -0.17 to -0.10 mm), respectively. Central VA did not decrease with CARE lenses. Peripheral VA decreased by 0.10 and 0.09 logMAR in the nasal and temporal zones, respectively. Analysis of fast progressors indicated that 39.7% of SVL wearing eyes progressed by ≤-0.50 D/year compared to 21.1% with CARE (p < 0.01). For AL, 56.0% of SVL children had an elongation ≥0.20 mm compared to 21.3% with CARE (p < 0.01).

Conclusions: In European children, myopia progression was significantly slower with CARE lenses compared with SVL after 1 year of lens wear. Further monitoring will provide a comprehensive evaluation of long-term efficacy.

目的:评价CARE眼镜镜片在减缓欧洲儿童近视进展中的疗效。方法:在一项为期2年的随机、平行组、双盲、多中心临床试验中,招募了234名6-13岁的欧洲儿童。所有受试者均为近视,前一年近视度数≥0.50 D,散光≤1.50 D,屈光参差≤1.00 D,近视度数≥0.50 D。治疗组采用带圆柱形环形屈光元件(CARE)的心肌镜片,对照组采用单视力镜片(SVL)。在基线、6个月和12个月测量轴长(AL)和SE。可穿戴性问卷分别于1周和3个月进行。分别记录配药时和3个月后的中央和周围视力(VA)。广义线性模型估计了SE和AL的变化,调整了晶状体类型、年龄和基线测量。结果:12个月后,佩戴CARE镜片的儿童近视进展较少,SE和AL进展差异(与SVL相比)分别为-0.21 D (CI: 0.10至0.32 D)和0.14 mm (CI: -0.17至-0.10 mm)。使用CARE隐形眼镜时,中央VA没有下降。外周VA在鼻区和颞区分别下降0.10和0.09 logMAR。快速进展分析表明,39.7%的SVL配戴者的近视进展速度≤-0.50 D/年,而CARE配戴者为21.1% (p)。结论:在欧洲儿童中,与SVL配戴1年后相比,CARE配戴者的近视进展速度明显慢于SVL。进一步的监测将提供长期疗效的综合评价。
{"title":"Clinical evaluation of MyoCare in Europe (CEME) for myopia management: One-year results.","authors":"Cristina Alvarez-Peregrina, Miguel Angel Sanchez-Tena, Cesar Villa-Collar, Clara Martinez-Perez, Beatriz de Corcuera-Terrero, Nicole Liu, Wayne Li, Padmaja Sankaridurg, Arne Ohlendorf","doi":"10.1111/opo.13517","DOIUrl":"10.1111/opo.13517","url":null,"abstract":"<p><strong>Aims: </strong>To evaluate the efficacy of CARE spectacle lenses in slowing myopia progression among European children.</p><p><strong>Methods: </strong>In a 2-year randomised, parallel-group, double-masked, multicentre clinical trial, 234 European children aged 6-13 years were enrolled. All participants were myopic, with a cycloplegic spherical equivalent refractive error (SE) between -0.75 D and -5.00 D, astigmatism ≤1.50 D, anisometropia ≤1.00 D and myopia progression of at least 0.50 D in the previous year. The treatment group received MyoCare spectacle lenses with cylinder annular refractive elements (CARE), the control group single-vision lenses (SVL). Axial length (AL) and SE were measured at baseline, 6 and 12 months. Wearability questionnaires were administered at 1 week and 3 months. Central and peripheral visual acuity (VA) was recorded at dispensing and after 3 months. Generalised linear models estimated changes in SE and AL, adjusting for lens type, age and baseline measurements.</p><p><strong>Results: </strong>After 12 months, children wearing CARE lenses showed less myopia progression, with a difference in SE and AL progression (compared to SVL) of -0.21 D (CI: 0.10 to 0.32 D) and 0.14 mm (CI: -0.17 to -0.10 mm), respectively. Central VA did not decrease with CARE lenses. Peripheral VA decreased by 0.10 and 0.09 logMAR in the nasal and temporal zones, respectively. Analysis of fast progressors indicated that 39.7% of SVL wearing eyes progressed by ≤-0.50 D/year compared to 21.1% with CARE (p < 0.01). For AL, 56.0% of SVL children had an elongation ≥0.20 mm compared to 21.3% with CARE (p < 0.01).</p><p><strong>Conclusions: </strong>In European children, myopia progression was significantly slower with CARE lenses compared with SVL after 1 year of lens wear. Further monitoring will provide a comprehensive evaluation of long-term efficacy.</p>","PeriodicalId":19522,"journal":{"name":"Ophthalmic and Physiological Optics","volume":" ","pages":"1025-1035"},"PeriodicalIF":2.8,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12087851/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144046473","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Can we predict which high myopes will develop pathological myopia? 我们能预测哪些高度近视会发展为病理性近视吗?
IF 2.4 3区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-06-01 Epub Date: 2025-03-10 DOI: 10.1111/opo.13462
Quan V Hoang, Ian Flitcroft, Nicola Rizzieri
{"title":"Can we predict which high myopes will develop pathological myopia?","authors":"Quan V Hoang, Ian Flitcroft, Nicola Rizzieri","doi":"10.1111/opo.13462","DOIUrl":"10.1111/opo.13462","url":null,"abstract":"","PeriodicalId":19522,"journal":{"name":"Ophthalmic and Physiological Optics","volume":" ","pages":"906-910"},"PeriodicalIF":2.4,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12087808/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143586379","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The International Myopia Institute (IMI) and consensus building. 国际近视研究所(IMI)和共识的建立。
IF 2.4 3区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-06-01 Epub Date: 2025-02-17 DOI: 10.1111/opo.13458
Nina Tahhan, Christine Wildsoet, Weizhong Lan, Serge Resnikoff
{"title":"The International Myopia Institute (IMI) and consensus building.","authors":"Nina Tahhan, Christine Wildsoet, Weizhong Lan, Serge Resnikoff","doi":"10.1111/opo.13458","DOIUrl":"10.1111/opo.13458","url":null,"abstract":"","PeriodicalId":19522,"journal":{"name":"Ophthalmic and Physiological Optics","volume":" ","pages":"897-898"},"PeriodicalIF":2.4,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12087806/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143441631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Does 0.01% atropine have a place as a myopia control therapy? 0.01%阿托品作为近视控制疗法是否有一席之地?
IF 2.4 3区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-06-01 Epub Date: 2025-04-07 DOI: 10.1111/opo.13490
Jason C Yam, Safal Khanal, John R Phillips
{"title":"Does 0.01% atropine have a place as a myopia control therapy?","authors":"Jason C Yam, Safal Khanal, John R Phillips","doi":"10.1111/opo.13490","DOIUrl":"10.1111/opo.13490","url":null,"abstract":"","PeriodicalId":19522,"journal":{"name":"Ophthalmic and Physiological Optics","volume":" ","pages":"929-935"},"PeriodicalIF":2.4,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12087867/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143795910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optical influence of myopia control spectacles at the retinal level: Effect of local light modulation. 近视控制眼镜在视网膜水平的光学影响:局部光调制的作用。
IF 2.8 3区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-06-01 Epub Date: 2025-04-12 DOI: 10.1111/opo.13515
Hakan Kaymak, Ann-Isabel Mattern, Birte Graff, Machteld Devenijn, Berthold Seitz, Hartmut Schwahn

Purpose: To investigate the influence of light modulation conferred by current designs of myopia control spectacles on retinal sensitivity.

Methods: Retinal sensitivity and scanning laser ophthalmoscopy (SLO) fundus images were obtained from nine healthy subjects using a Macular Integrity Assessment microperimeter with current myopia control spectacle lenses: MyoCare, Stellest, MiYOSMART and DOT. Respectively powered single vision lenses and a 0.8-grade Bangerter occlusion foil (BF) served as comparative controls.

Results: Using the SLO image, one can visualise the areas of light modulation of the various myopia control lens designs at the level of the retina. Clear zone sizes differ between lens designs, with the DOT lens having the smallest area. Retinal sensitivity in areas of local light modulation was not reduced for the Stellest and MyoCare lenses, but declined with the MiYOSMART lens, suggesting a more prominent local light modulation. The DOT lenses produced a significant reduction in overall retinal sensitivity, although the reduction with the BF was greater. In all instances, retinal sensitivity remained well above the range considered normal for a healthy retina.

Conclusions: None of the lenses tested produced a clinically relevant reduction in retinal sensitivity and all scored significantly better than the lowest (that is, 0.8) grade BF. Given that current myopia control spectacles do not show consistent treatment effects as required to slow progression effectively over extended periods, there appears to be a subtle, yet crucial difference in spatial light modulation among these myopia control spectacle lenses. Seemingly similar lens designs cannot be assumed to have equivalent treatment effects; a thorough assessment of these nuances is essential to ensure accurate claims regarding their long-term efficacy.

目的:探讨当前近视控制眼镜设计中光调制对视网膜敏感性的影响。方法:采用黄斑完整性评估微周仪对9名健康受试者进行视网膜敏感度和扫描激光眼底成像,并配以现有的近视控制镜片:心肌、Stellest、MiYOSMART和DOT。分别以动力单视力透镜和0.8级Bangerter遮挡箔(BF)作为对照。结果:使用SLO图像,可以看到各种近视控制晶状体设计在视网膜水平上的光调制区域。透明区大小不同的镜头设计,与DOT镜头具有最小的面积。Stellest和心肌晶状体在局部光调制区域的视网膜敏感性没有降低,但MiYOSMART晶状体的敏感性下降,表明局部光调制更突出。DOT透镜产生了视网膜整体敏感度的显著降低,尽管BF的降低更大。在所有情况下,视网膜的敏感度都远远高于健康视网膜的正常范围。结论:所有测试的镜片都没有产生与临床相关的视网膜敏感性降低,并且所有镜片的评分都明显优于最低(即0.8)级BF。鉴于目前的近视控制眼镜并没有显示出持续的治疗效果,因此这些近视控制眼镜镜片之间的空间光调制似乎存在着微妙而关键的差异。表面上相似的透镜设计不能假设有相同的治疗效果;对这些细微差别的彻底评估对于确保其长期疗效的准确声明至关重要。
{"title":"Optical influence of myopia control spectacles at the retinal level: Effect of local light modulation.","authors":"Hakan Kaymak, Ann-Isabel Mattern, Birte Graff, Machteld Devenijn, Berthold Seitz, Hartmut Schwahn","doi":"10.1111/opo.13515","DOIUrl":"10.1111/opo.13515","url":null,"abstract":"<p><strong>Purpose: </strong>To investigate the influence of light modulation conferred by current designs of myopia control spectacles on retinal sensitivity.</p><p><strong>Methods: </strong>Retinal sensitivity and scanning laser ophthalmoscopy (SLO) fundus images were obtained from nine healthy subjects using a Macular Integrity Assessment microperimeter with current myopia control spectacle lenses: MyoCare, Stellest, MiYOSMART and DOT. Respectively powered single vision lenses and a 0.8-grade Bangerter occlusion foil (BF) served as comparative controls.</p><p><strong>Results: </strong>Using the SLO image, one can visualise the areas of light modulation of the various myopia control lens designs at the level of the retina. Clear zone sizes differ between lens designs, with the DOT lens having the smallest area. Retinal sensitivity in areas of local light modulation was not reduced for the Stellest and MyoCare lenses, but declined with the MiYOSMART lens, suggesting a more prominent local light modulation. The DOT lenses produced a significant reduction in overall retinal sensitivity, although the reduction with the BF was greater. In all instances, retinal sensitivity remained well above the range considered normal for a healthy retina.</p><p><strong>Conclusions: </strong>None of the lenses tested produced a clinically relevant reduction in retinal sensitivity and all scored significantly better than the lowest (that is, 0.8) grade BF. Given that current myopia control spectacles do not show consistent treatment effects as required to slow progression effectively over extended periods, there appears to be a subtle, yet crucial difference in spatial light modulation among these myopia control spectacle lenses. Seemingly similar lens designs cannot be assumed to have equivalent treatment effects; a thorough assessment of these nuances is essential to ensure accurate claims regarding their long-term efficacy.</p>","PeriodicalId":19522,"journal":{"name":"Ophthalmic and Physiological Optics","volume":" ","pages":"995-1003"},"PeriodicalIF":2.8,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12087823/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144032658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Myopia is predominantly genetic or predominantly environmental? 近视主要是遗传的还是环境的?
IF 2.4 3区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-06-01 Epub Date: 2025-03-03 DOI: 10.1111/opo.13464
Virginie J M Verhoeven, Ian G Morgan, Jeremy A Guggenheim
{"title":"Myopia is predominantly genetic or predominantly environmental?","authors":"Virginie J M Verhoeven, Ian G Morgan, Jeremy A Guggenheim","doi":"10.1111/opo.13464","DOIUrl":"10.1111/opo.13464","url":null,"abstract":"","PeriodicalId":19522,"journal":{"name":"Ophthalmic and Physiological Optics","volume":" ","pages":"911-917"},"PeriodicalIF":2.4,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12087860/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143542796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is central vision (and a fovea) needed for emmetropisation? 都市化需要中央视力(和中央凹)吗?
IF 2.8 3区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-06-01 Epub Date: 2025-03-20 DOI: 10.1111/opo.13494
Frank Schaeffel, Christine Wildsoet, Ranjay Chakraborty
{"title":"Is central vision (and a fovea) needed for emmetropisation?","authors":"Frank Schaeffel, Christine Wildsoet, Ranjay Chakraborty","doi":"10.1111/opo.13494","DOIUrl":"10.1111/opo.13494","url":null,"abstract":"","PeriodicalId":19522,"journal":{"name":"Ophthalmic and Physiological Optics","volume":" ","pages":"941-946"},"PeriodicalIF":2.8,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12087870/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143663729","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Ophthalmic and Physiological Optics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1